The cost-effectiveness of a universal influenza vaccination program for adults aged 50–64 years in Australia

This publication has 34 references indexed in Scilit:

• Influenza-related hospitalisation and death in Australians aged 50 years and older
  Vaccine, 2008
• The Cost-Effectiveness of Influenza Vaccination for People Aged 50 to 64 Years: An International Model
  Value in Health, 2007
• Influenza Vaccination
  American Journal of Preventive Medicine, 2006
• The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age
  Vaccine, 2006
• Influenza‐Associated Mortality in Hong Kong
  Clinical Infectious Diseases, 2004
• Influenza-Associated Hospitalizations in the United States
  JAMA, 2004
• The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines
  Vaccine, 2003
• Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza
  Archives of internal medicine (1960), 2001
• Influenza-Associated Morbidity and Mortality in Young and Middle-Aged Women
  JAMA, 1999
• Economic Impact of Providing Workplace Influenza Vaccination
  PharmacoEconomics, 1999